Venous thromboembolism (VTE) is the third most common cause of vascular mortality
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In …

The incidence of venous thromboembolic disease increases by a factor of four with
pregnancy, and in developed countries pulmonary embolus is the leading cause of maternal …

Background The use of anticoagulant therapy during pregnancy is challenging because of
the potential for both fetal and maternal complications. This guideline focuses on the …

Background Objective testing for DVT is crucial because clinical assessment alone is
unreliable and the consequences of misdiagnosis are serious. This guideline focuses on the …

Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep
vein thrombosis (DVT), is a serious and potentially fatal condition. Treatment and prevention …

Background: The risk for venous thromboembolism during pregnancy or postpartum is
uncertain. Objectives: To estimate the relative and absolute risk for deep venous thrombosis …

OBJECTIVE: The purpose of this study was to estimate the incidence, risk factors, and
mortality from pregnancy-related venous thromboembolism. STUDY DESIGN: The …

Objective To present an approach, based on current evidence, for the diagnosis, treatment,
and thromboprophylaxis of venous thromboembolism in pregnancy and postpartum …

Background: Venous thrombosis is one of the leading causes of maternal morbidity and
mortality. Objective: In the MEGA study, we evaluated pregnancy and the postpartum period …

This article discusses the management of venous thromboembolism (VTE) and
thrombophilia, as well as the use of antithrombotic agents, during pregnancy and is part of …